Category: Pharma Industry

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Mississippi, Maryland

July 18, 2024 William Newton, Associate Editor/Senior Writer & Shannon Young, Associate Editor/Senior Writer Views

Federal district courts in Maryland and Mississippi saw various legal actions related to state 340B contract pharmacy access laws in the past week.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

SK Life Science Posts Refund Notice; Dr. Reddy’s and Pfizer Issue NDC Changes

July 18, 2024 Bella Czajkowski, National Correspondent Views

Amgen announced a change to the national drug code for its osteoporosis drug, Prolia.

SK Life Science issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. Multiple drug manufacturers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

CMS Proposes Rule to Exclude 340B Claims from Inflation Rebates; Reflects ‘Stronger Understanding’ of 340B than IRA Negotiation Guidance, Says Attorney

July 16, 2024 William Newton, Associate Editor/Senior Writer Views

CMS recently proposed a rule to fulfill its statutory obligation to exclude 340B claims from Medicare inflationary rebates.

The Centers for Medicare & Medicaid Services (CMS) has outlined how it plans to identify 340B claims to remove when [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Study Finds Oncology Markups at 340B Pediatric Hospitals; AHA Slams Study and Funder

July 16, 2024 Shannon Young, Associate Editor/Senior Writer Views

New research looked at the prices 340B-enrolled pediatric hospitals charged for pediatric oncology drugs.

The rates 340B pediatric hospitals negotiate with payers for new pediatric oncology drugs often exceed a medication’s average sale price, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sumitomo Loosens 340B Contract Pharmacy Restrictions in Five More States

July 16, 2024 William Newton, Associate Editor/Senior Writer Views

Sumitomo Pharma America loosened or ended its 340B contract pharmacy restrictions in an additional five states.

Drugmaker Sumitomo Pharma America (SMPA) is partially or fully exempting providers in five additional states from its 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Pharma-Linked Conservative Nonprofit Launches Ad Campaign to ‘Stop the Feeding Frenzy’ in 340B

July 11, 2024 William Newton, Associate Editor/Senior Writer Views

The Council for Citizens Against Government Waste has launched a new ad campaign that criticizes the 340B program.

An anti-government waste group with ties to the drug industry is urging lawmakers to “stop the feeding frenzy” in the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Industry Takes Issue with IRA’s Drug Negotiation Guidance

July 11, 2024 Shannon Young, Associate Editor/Senior Writer Views

PhRMA recently urged CMS to establish a neutral clearinghouse and require accurate use of 340B claim modifiers to address nonduplication in its final guidance for Medicare drug price negotiations under the IRA.

Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Apotex to Issue Refunds to 340B Covered Entities

July 11, 2024 Shannon Young, Associate Editor/Senior Writer Views

Apotex Corp. announced in a July 2 notice to 340B providers that it will issue refunds to 340B covered entities that purchased any of nearly 400 products.

A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Astellas Suspends its Contract Pharmacy Restrictions in More States; BMS and Sanofi Also Announce State Exemptions

July 9, 2024 Shannon Young, Associate Editor/Senior Writer Views

Astellas Pharma announced the suspension of its contract pharmacy policy in Maryland and Mississippi.

A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

AbbVie, AstraZeneca Sue Minnesota Over Contract Pharmacy Access Law

July 9, 2024 Shannon Young, Associate Editor/Senior Writer Views

AbbVie and AstraZeneca filed a pair of lawsuits to block Minnesota's law barring manufacturer 340B contract pharmacy restrictions.

Two major drug manufacturers are suing Minnesota to block a new 340B contract pharmacy access law, which took effect this [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live